Stay updated on PD-1 Inhibitor & Chemo With Radiation in Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the PD-1 Inhibitor & Chemo With Radiation in Advanced NSCLC Clinical Trial page.

Latest updates to the PD-1 Inhibitor & Chemo With Radiation in Advanced NSCLC Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.2.SummaryDifference1%
- Check22 days agoNo Change Detected
- Check43 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check57 days agoChange DetectedThe webpage has been updated to reflect a new version (v2.15.0) and includes the names of principal investigators and collaborators associated with a study on advanced non-small cell lung cancer. Additionally, specific details about the inclusion criteria for the study have been added.SummaryDifference35%
- Check65 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check72 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check108 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1.0%
Stay in the know with updates to PD-1 Inhibitor & Chemo With Radiation in Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-1 Inhibitor & Chemo With Radiation in Advanced NSCLC Clinical Trial page.